| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $69,078,416 ) (Continued on the next page) |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AR084212 | Gene Therapy for PXE: Breaking the Barrier of Ectopic Calcification | 001 | 2 | NIH | 4/28/2025 | $0 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AR084212 | Gene Therapy for PXE: Breaking the Barrier of Ectopic Calcification | 000 | 2 | NIH | 4/16/2025 | $185,328 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 001 | 3 | NIH | 6/4/2025 | $58,972 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 000 | 3 | NIH | 11/15/2024 | $530,756 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA284017 | Deciphering the role of NELFE in modulating MYC signaling in HCC | 000 | 3 | NIH | 7/21/2025 | $355,376 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS112504 | Investigating the Role and Regulation of the MAP7 Family Proteins in Axonal Morphogenesis and Function | 001 | 5 | NIH | 8/5/2025 | $42,810 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS112504 | Investigating the Role and Regulation of the MAP7 Family Proteins in Axonal Morphogenesis and Function | 000 | 5 | NIH | 11/27/2024 | $385,296 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM146116 | Relevance of mitochondrial calcium uniporter for mitochondrial myopathy | 000 | 3 | NIH | 8/12/2025 | $411,840 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD112492 | Breastfeeding Education Support Tool for Baby | 003 | 2 | NIH | 9/19/2025 | $208,255 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD112492 | Breastfeeding Education Support Tool for Baby | 002 | 2 | NIH | 9/17/2025 | -$208,255 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD112492 | Breastfeeding Education Support Tool for Baby | 001 | 2 | NIH | 8/7/2025 | $208,255 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD112492 | Breastfeeding Education Support Tool for Baby | 000 | 2 | NIH | 7/22/2025 | $260,362 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR076941 | Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium | 001 | 5 | NIH | 6/2/2025 | $46,055 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR076941 | Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium | 000 | 5 | NIH | 12/11/2024 | $592,145 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK138834 | Targeting visceral pain through intestinal neuropod cell GUCY2C signaling | 000 | 3 | NIH | 8/15/2025 | $681,303 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL122124 | Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics | 001 | 8 | NIH | 7/30/2025 | $54,747 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL122124 | Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics | 000 | 8 | NIH | 11/21/2024 | $492,718 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R00NS128258 | Structural and Functional Studies on Proton-activated Chloride (PAC) Channel | 000 | 3 | NIH | 11/15/2024 | $248,999 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R00NS128258 | Structural and Functional Studies on Proton-activated Chloride (PAC) Channel | 001 | 4 | NIH | 7/30/2025 | $248,999 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 003 | 5 | NIH | 6/12/2025 | -$44,845 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL175371 | Role of tRNA- and rRNA-derived RNAs in acute lung injury | 000 | 2 | NIH | 7/16/2025 | $626,956 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 001 | 5 | NIH | 4/10/2025 | -$245,704 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 000 | 5 | NIH | 1/1/2025 | $321,165 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R33HL173910 | RNA-based therapeutics for hemostasis and thrombosis | 001 | 2 | NIH | 7/3/2025 | $54,600 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R33HL173910 | RNA-based therapeutics for hemostasis and thrombosis | 000 | 2 | NIH | 4/15/2025 | $491,398 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082460 | The role of endogenous low molecular weight mineralization inhibitors in spine health | 000 | 2 | NIH | 11/13/2024 | $599,407 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T2554964 | Addiction Medicine Fellowship | 00 | 1 | HRSA | 7/1/2025 | $600,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | H79TI087343 | Project TINES (Trauma-Informed Nursing Education on Substance Use) | 001 | 2 | SAMHSA | 9/26/2025 | -$1 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | H79TI087343 | Project TINES (Trauma-Informed Nursing Education on Substance Use) | 000 | 2 | SAMHSA | 9/24/2025 | $298,758 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | UH3CA247605 | Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy | 000 | 5 | NIH | 8/28/2025 | $420,407 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173436 | Platelets as regulator of non-neurological complications of ischemic stroke | 000 | 1 | NIH | 6/12/2025 | $779,952 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA266592 | The Role of IL-15 in Cutaneous T-cell Lymphoma Progression | 000 | 3 | NIH | 6/27/2025 | $356,850 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 001 | 4 | NIH | 6/11/2025 | $54,001 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI156384 | Role of IL-7R in CNS autoimmunity | 000 | 4 | NIH | 11/26/2024 | $378,300 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 4 | NIH | 1/9/2025 | $486,021 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173113 | Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | 001 | 2 | NIH | 7/25/2025 | $56,651 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173113 | Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | 000 | 2 | NIH | 3/25/2025 | $509,870 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS121143 | Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS | 000 | 3 | NIH | 4/4/2025 | $351,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG078609 | Promoting regenerative repair of aged cartilage | 002 | 3 | NIH | 8/11/2025 | $57,466 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | H79SM087225 | Alternative Diversion to Behavioral Health Crises in Northeastern Pennsylvania. | 001 | 4 | SAMHSA | 9/22/2025 | $349,992 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | P01HL180318 | Exploiting emerging ideas in G protein-coupled receptor biology and pharmacology to treat asthma | 000 | 1 | NIH | 9/16/2025 | $2,456,717 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL176891 | Integration of platelets and coagulation to maintain hemostasis in vivo | 000 | 1 | NIH | 9/2/2025 | $457,514 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21HL179322 | Circulating immunoactive small RNAs in COPD as biomarkers. | 000 | 1 | NIH | 8/27/2025 | $234,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA304161 | Investigating and targeting NSD2 mutation-driven leukemia transformation | 000 | 1 | NIH | 8/26/2025 | $484,405 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | P30CA056036 | Translational Research in Cancer | 002 | 25 | NIH | 9/9/2025 | $150,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | S15OD039813 | Optimice 100-Cage IVC System | 000 | 1 | NIH | 7/30/2025 | $347,945 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EB032333 | Monodisperse Microbubbles for Noninvasive Pressure Estimation | 001 | 4 | NIH | 5/22/2025 | $600,307 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F32HD120236 | The role of subjective values and dopamine availability in incentive-based motor learning | 000 | 1 | NIH | 7/30/2025 | $78,520 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS079702 | Respiratory interneuron circuit plasticity: promoting recovery of diaphragm function after spinal cord injury | 002 | 13 | NIH | 6/18/2025 | $542,250 |
|
